Evaluation of low-dose colchicine in patients with cardiopulmonary bypass: study protocol for a randomised controlled trial
Main Authors: | HE Zhang, Jun Pan, Hai-Tao Zhang, Xikun Han, Ze-Shi Li, Kai Zhong, Tuo Pan, Dong-Jin Wang, Xinyi Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/2/e050577.full |
Similar Items
-
The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial
by: Tuo Pan, et al.
Published: (2023-02-01) -
The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
by: Tuo Pan, et al.
Published: (2023-01-01) -
Corrigendum: The neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass
by: Tuo Pan, et al.
Published: (2023-03-01) -
Comparison of immune cell profiles associated with heatstroke, sepsis, or cardiopulmonary bypass: Study protocol for an exploratory, case-control study trial
by: Juan Wu, et al.
Published: (2023-04-01) -
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care
by: Roddy, E, et al.
Published: (2019)